Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-12-052478)

Filing Details

Accession Number:: 0001181431-12-052478
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-10-01 16:02:16
Reporting Period:: 2012-09-27

Filing Date:: 2012-10-01
Accepted Time:: 2012-10-01 16:02:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
906709	Nektar Therapeutics	NKTR	Pharmaceutical Preparations (2834)	943134940

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1229877	A Christopher Kuebler	C/O Nektar Therapeutics 455 Mission Bay Boulevard South San Francisco CA 94158		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-09-27	12,500	$8.66	32,500	No	4	M	Direct
Common Stock	Disposition	2012-09-27	12,500	$10.66	20,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2012-09-27	12,500	$0.00	12,500	$8.66

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2003-12-05	2012-12-04	No	4	M	Direct

Footnotes

Stock option exercise and sale executed under an existing trading plan previously adopted by the Reporting Person under Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. The stock option being exercised was set to expire on December 4, 2012.